Dental products company Dentsply Sirona (NASDAQ: XRAY) will be reporting results this Thursday after market hours. Here’s what investors should know.
Dentsply Sirona beat analysts’ revenue expectations last quarter, reporting revenues of $880 million, flat year on year. It was a satisfactory quarter for the company, with a decent beat of analysts’ full-year EPS guidance estimates but EPS in line with analysts’ estimates.
Is Dentsply Sirona a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, the market is expecting Dentsply Sirona’s revenue to decline 4.6% year on year, in line with the 4.9% decrease it recorded in the same quarter last year.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business will stay the course heading into earnings. Dentsply Sirona has missed Wall Street’s revenue estimates multiple times over the last two years.
Looking at Dentsply Sirona’s peers in the healthcare equipment and supplies segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Henry Schein delivered year-on-year revenue growth of 6.7%, beating analysts’ expectations by 2.6%, and Align Technology reported revenues up 4.3%, in line with consensus estimates. Align Technology traded down 3.7% following the results.
Read our full analysis of Henry Schein’s results here and Align Technology’s results here.
Investors in the healthcare equipment and supplies segment have had steady hands going into earnings, with share prices up 1.4% on average over the last month. Dentsply Sirona is up 15.7% during the same time and is heading into earnings with an average analyst price target of $13.44 (compared to the current share price of $14.25).
WHILE YOU’RE HERE: The Next Palantir? One satellite company captures images of every point on Earth. Every single day. The Pentagon wants it. Hedge funds are using it to beat earnings. You’ve probably never heard of it.
This is what the early days of Palantir looked like before it became a giant. Same playbook. Different technology. If you missed Palantir, you need to see this. Claim The Stock Ticker for Free HERE.
